epirubicin has been researched along with Drug Abuse, Intravenous in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
FoĆ , R; Gavosto, F; Monfardini, S; Tirelli, U; Vaccher, E | 1 |
1 other study(ies) available for epirubicin and Drug Abuse, Intravenous
Article | Year |
---|---|
Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus. Gruppo Italiano Cooperativo AIDS & Tumori (GICAT).
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Opportunistic Infections; Prednisone; Procarbazine; Remission Induction; Substance Abuse, Intravenous; Survival Rate; Vinblastine; Vincristine | 1991 |